Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_provenance.
- NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_assertion description "[Thus, we have shown that rosiglitazone appears to have direct anti-atherosclerotic effects in an animal model of diabetes-associated atherosclerosis which are at least partly due to effects on VCAM-1, ICAM-1, MCP-1 and P-selectin expression which leads to decreased leukocyte adhesion and macrophage infiltration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_provenance.
- NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_assertion evidence source_evidence_literature NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_provenance.
- NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_assertion SIO_000772 18093596 NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_provenance.
- NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_assertion wasDerivedFrom befree-2016 NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_provenance.
- NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_assertion wasGeneratedBy ECO_0000203 NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_provenance.
- befree-2016 importedOn "2016-02-19" NP646278.RA2pzFir6jQr7AJEeYqrwJD0b8p1pwyNuKvBPwVwLWgDI130_provenance.